Analysed SCISPARC LTD (SPRC:NASDAQ) News Sources
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
10-03-2026
yahoo.com
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
10-03-2026
yahoo.com
NeuroThera Labs Announces Publication of International Patent in Collaboration With Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
11-03-2026
yahoo.com
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
12-03-2026
yahoo.com
NeuroThera Labs - Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
16-03-2026
yahoo.com
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
16-03-2026
yahoo.com
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
28-05-2026
yahoo.com
NeuroThera Labs Inc. Announces Closing of Acquisition of Majority Stake in CliniQuantum Ltd.
03-06-2026
yahoo.com
What is the current price of SCISPARC LTD (SPRC:NASDAQ)?
The current price of SCISPARC LTD (SPRC:NASDAQ) is $9.31.
SCISPARC LTD (SPRC:NASDAQ) absolute price change since previous trading day?
The absolute price change of SCISPARC LTD (SPRC:NASDAQ) since the previous trading day is $-1.11.
SCISPARC LTD (SPRC:NASDAQ) percentage price change since previous trading day?
The percentage price change of SCISPARC LTD (SPRC:NASDAQ) since the previous trading day is -10.6526%.
What is the most recent average sentiment score for SCISPARC LTD (SPRC:NASDAQ)?
The most recent average sentiment score for SCISPARC LTD (SPRC:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for SCISPARC LTD (SPRC:NASDAQ)?
The most recent sentiment for SCISPARC LTD (SPRC:NASDAQ) is .
SEC-8K** Filing Available For SCISPARC LTD (SPRC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.